Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome

References

Page 1

	Year	Citations
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertility and Sterility Long-term Health RisksInfertilityFemale InfertilityDiagnostic CriteriaReproductive Health	2004	8.9K
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population Ricardo Azziz, Keslie S. Woods, Rosario Reyna, The Journal of Clinical Endocrinology & Metabolism FertilityReproductive HealthGynecologyPolycystic Ovary SyndromeUnselected Population	2004	2.7K
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN David Ferriman, J. D. GALLWEY The Journal of Clinical Endocrinology & Metabolism Body CompositionClinical ProblemsSemiquantitative AssessmentHuman GrowthMenopause	1961	2.5K
Men at risk: occupation and male infertility Paul Claman Fertility and Sterility InfertilityAndrologyMale FertilityFertilityGender Studies	2004	2.4K
Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. W. Oelkers, Jean Michel Foidart, N. Dombrovicz, The Journal of Clinical Endocrinology & Metabolism	1995	223
Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic Hyperandrogenism: Opposite Effects on Adipocytokines and Body Adiposity Lourdes Ibáñez, Francis de Zegher The Journal of Clinical Endocrinology & Metabolism	2004	174
Aminolevulinic acid hydrochloride with photodynamic therapy: efficacy outcomes and recurrence 4 years after treatment. PubMed	2002	173
Drospirenone for the Treatment of Hirsute Women with Polycystic Ovary Syndrome: A Clinical, Endocrinological, Metabolic Pilot Study Maurizio Guido, Daniela Romualdi, Maddalena Giuliani, The Journal of Clinical Endocrinology & Metabolism	2004	156
An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen Kelly Parsey, Annpey Pong Contraception ContraceptionHormonal ContraceptiveOral ContraceptiveMedicineReproductive Health	2000	149
Effects of Oral Zinc and Vitamin A in Acne G Michaëlsson Archives of Dermatology	1977	136

Page 1